[Skip to Content]
[Skip to Content Landing]
February 1963

Effects of a Hallucinogenic Agent in Totally Blind Subjects

Author Affiliations

Present address, Dr. Krill: Department of Surgery, Section of Ophthalmology, The University of Chicago, 950 East 59th St., Chicago 37.; From the Departments of Ophthalmology and Preventive Medicine, University of Illinois College of Medicine.

Arch Ophthalmol. 1963;69(2):180-185. doi:10.1001/archopht.1963.00960040186009

A previous study demonstrated that lysergic acid diethylamide (LSD) induced measurable changes in human retinal function while visual hallucinations and illusions were being experienced.1 The changes were evident in both dark-adaptation and electroretinographic studies and were interpreted as mildly hypoxic or toxic retinal effects of LSD. In the dark-adaptation curve, LSD delayed the rod-cone break and elevated the entire rod threshold. In the electroretinogram (ERG), the drug increased the scotopic bwave amplitudes and in some subjects also increased the scotopic a-wave amplitudes.

Because hallucinations and illusions were reported only when measurable ERG and dark-adaptation changes occurred, a possible retinal role in the induction of hallucinations was considered. Consequently, the present study was undertaken to clarify the role of a functioning retina in the induction of LSD-induced visual changes by studying subjects with total blindness (no light perception) and, insofar as could be determined, normal central nervous system

First Page Preview View Large
First page PDF preview
First page PDF preview